Distinct molecular determinants govern syntaxin 1A-mediated inactivation and G-protein inhibition of N-type calcium channels

J Neurosci. 2001 May 1;21(9):2939-48. doi: 10.1523/JNEUROSCI.21-09-02939.2001.

Abstract

We have reported recently that syntaxin 1A mediates two effects on N-type channels transiently expressed in tsA-201 cells: a hyperpolarizing shift in the steady-state inactivation curve as well as a tonic inhibition of the channel by G-protein betagamma subunits (Jarvis et al., 2000). Here we have examined some of the molecular determinants and factors that modulate the action of syntaxin 1A on N-type calcium channels. With the additional coexpression of SNAP25, the syntaxin 1A-induced G-protein modulation of the channel became reduced in magnitude by approximately 50% but nonetheless remained significantly higher than the low levels of background inhibition seen with N-type channels alone. In contrast, coexpression of nSec-1 did not reduce the syntaxin 1A-mediated G-protein inhibition; however, interestingly, nSec-1 was able to induce tonic G-protein inhibition even in the absence of syntaxin 1A. Both SNAP25 and nSec-1 blocked the negative shift in half-inactivation potential that was induced by syntaxin 1A. Activation of protein kinase C via phorbol esters or site-directed mutagenesis of three putative PKC consensus sites in the syntaxin 1A binding region of the channel (S802, S896, S898) to glutamic acid (to mimic a permanently phosphorylated state) did not affect the syntaxin 1A-mediated G-protein modulation of the channel. However, in the S896E and S898E mutants, or after PKC-dependent phosphorylation of the wild-type channels, the susceptibility of the channel to undergo shifts in half-inactivation potential was removed. Thus, separate molecular determinants govern the ability of syntaxin 1A to affect N-type channel gating and its modulation by G-proteins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs / genetics
  • Amino Acid Substitution / drug effects
  • Amino Acid Substitution / genetics
  • Antigens, Surface / metabolism*
  • Antigens, Surface / pharmacology
  • Binding Sites / genetics
  • Calcium Channels, N-Type / drug effects
  • Calcium Channels, N-Type / metabolism*
  • Cell Line
  • GTP-Binding Proteins / metabolism*
  • GTP-Binding Proteins / pharmacology
  • Humans
  • Ion Channel Gating / drug effects
  • Ion Channel Gating / genetics
  • Kidney / cytology
  • Kidney / metabolism
  • Membrane Proteins*
  • Molecular Sequence Data
  • Munc18 Proteins
  • Mutagenesis, Site-Directed / genetics
  • Nerve Tissue Proteins / analysis
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / cerebrospinal fluid*
  • Nerve Tissue Proteins / metabolism*
  • Nerve Tissue Proteins / pharmacology
  • Patch-Clamp Techniques
  • Phosphorylation / drug effects
  • Point Mutation
  • Protein Kinase C / metabolism
  • Structure-Activity Relationship
  • Synaptosomal-Associated Protein 25
  • Syntaxin 1
  • Transfection
  • Vesicular Transport Proteins*

Substances

  • Antigens, Surface
  • Calcium Channels, N-Type
  • Membrane Proteins
  • Munc18 Proteins
  • Nerve Tissue Proteins
  • SNAP25 protein, human
  • STX1A protein, human
  • Synaptosomal-Associated Protein 25
  • Syntaxin 1
  • Vesicular Transport Proteins
  • Protein Kinase C
  • GTP-Binding Proteins